CorTec received a second Breakthrough Device Designation from the FDA for the Brain Interchange system, enabling people with non-progressive quadriplegia to control a computer cursor through thought alone.

CorTec is a German clinical-stage neurotechnology company, founded in 2010, with one purpose: to restore independence to people with neurological conditions. We build implantable systems that communicate directly with the nervous system. Our Brain Interchange™ platform, a fully implantable, bidirectional brain-computer interface (BCI), is now in clinical evaluation with patients, opening entirely new treatment modalities while gathering the data that, with AI, unlocks future therapies. We also provide implant technology to others in the global neurotherapy field, so together we can restore independence at a scale none of us could reach alone.